Avodart Cost in Minnesota 2026: Prices, Insurance, Medicaid and Compounded Options

What Does Avodart Actually Cost in Minnesota Right Now?

Generic dutasteride 0.5 mg capsules cost approximately $25 per month at Minnesota retail pharmacies when paying cash in 2026, while the brand-name Avodart carries a manufacturer list price of around $290 per month. The gap between those two numbers is the single most important fact for any Minnesota patient comparing options.

Brand-name Avodart, manufactured by GSK (GlaxoSmithKline), launched in the United States in 2001 and lost patent exclusivity in 2015. Since then, multiple generic manufacturers have entered the market, and the competitive pressure has driven cash prices down dramatically. A 30-capsule supply of generic dutasteride 0.5 mg at large Minnesota chains (Walgreens, CVS, Target, Hy-Vee, Coborn's) typically falls between $20 and $35 depending on the pharmacy and the discount program applied.

Prices do vary by zip code within Minnesota. Metro-area pharmacies in Minneapolis and Saint Paul tend to have slightly more competitive pricing than rural outstate locations in areas like Bemidji or International Falls, where fewer pharmacies compete for the same prescription volume. Using a discount card through GoodRx or RxSaver can close that gap for patients in lower-volume markets.

The FDA approved dutasteride 0.5 mg for benign prostatic hyperplasia (BPH) in 2001 under the brand name Avodart. Prescribing information is available on the FDA's access data portal. It is also prescribed off-label for androgenetic alopecia (male and female pattern hair loss), a use supported by clinical evidence but not reflected in the FDA label.

Minnesota Retail Price Comparison (2026 estimates)

| Source | Monthly Cost | |---|---| | Brand Avodart (GSK, no insurance) | ~$290 | | Generic dutasteride (cash, retail MN) | ~$25 | | Compounded dutasteride (503A pharmacy, MN) | ~$40 | | Generic with GoodRx-type coupon | $18-$30 | | Generic with Medicare Part D (typical copay tier) | $0-$47 |

Does Minnesota Medicaid Cover Dutasteride?

Minnesota Medicaid (called Medical Assistance, or MA) does cover dutasteride, but requires prior authorization for most beneficiaries. The prior authorization process exists to confirm the BPH diagnosis and to document that the patient has not had an adequate response to, or is not a candidate for, an alpha-blocker such as tamsulosin alone before adding a 5-alpha reductase inhibitor.

Prescribers submit the PA request through the Minnesota Department of Human Services (DHS) drug prior authorization process. Standard turnaround under MA rules is typically 72 hours for routine requests. Urgent PAs can be processed same-day if the prescriber documents clinical urgency.

Minnesota Medical Assistance follows a preferred drug list (PDL). Generic dutasteride is generally placed in a lower-cost tier than brand Avodart on that list, meaning the PA pathway for generic dutasteride tends to be straightforward when BPH documentation is in order. Off-label use for androgenetic alopecia is less consistently covered; MA reviewers will generally deny the PA if the diagnosis code is hair loss rather than BPH (ICD-10 N40.1).

For Minnesota residents enrolled in a Medicaid managed care organization (such as UCare, Blue Plus, Hennepin Health, or South Country Health Alliance), the PA process runs through the managed care plan's pharmacy department rather than directly through DHS. Timelines and specific documentation requirements vary slightly by plan.

Key documentation a Minnesota prescriber needs for a dutasteride PA under Medical Assistance:

• ICD-10 code N40.1 (BPH with lower urinary tract symptoms) or N40.0
• Documented prostate volume or PSA consistent with BPH (or urology note)
• Trial of an alpha-blocker if applicable, or clinical reason for skipping that step
• Prescriber NPI enrolled with Minnesota DHS

Is Compounded Dutasteride Legal in Minnesota?

Compounded dutasteride is legal in Minnesota when prepared by a licensed 503A pharmacy operating under state board of pharmacy oversight. Section 503A of the federal Food, Drug, and Cosmetic Act allows state-licensed pharmacies to compound drug preparations for individual patients when a valid prescription exists. Minnesota Board of Pharmacy rules are aligned with those federal requirements.

Several things are worth clarifying here. A 503A pharmacy compounds for a specific named patient based on an individual prescription. That is different from a 503B outsourcing facility, which can produce larger batches without individual prescriptions. For most retail and telehealth compounding scenarios in Minnesota, 503A is the relevant category.

Compounded dutasteride typically costs around $40 per month from a licensed 503A pharmacy, which is notably higher than the $25 generic retail cash price. Why would a patient choose it? The main reasons are: custom dosing combinations (for example, a topical formulation for hair loss that combines dutasteride with minoxidil and other agents), patient difficulty swallowing capsules, or a prescriber's preference for a specific vehicle. Pure oral dutasteride 0.5 mg compounded from powder will not save a Minnesota patient money compared to the commercial generic.

Topical compounded dutasteride for androgenetic alopecia is an area of active clinical interest. A randomized controlled trial by Eun et al. (N=40 to 24 weeks) found that 0.02% topical dutasteride solution significantly improved hair count compared to placebo in men with androgenetic alopecia, with minimal systemic absorption at that concentration. PubMed PMID 20691790 This formulation is not commercially available, so compounding is the only route a Minnesota prescriber can use to offer it.

Patients should verify that any 503A pharmacy filling their prescription holds a current Minnesota Board of Pharmacy license. The Minnesota Board of Pharmacy license lookup is publicly available at the state portal.

Which Insurance Plans Cover Avodart in Minnesota, and at What Tier?

Most Minnesota commercial insurance plans cover generic dutasteride; fewer cover brand Avodart at a competitive tier. The specific cost-sharing depends on the plan's formulary and the tier assignment.

Medicare Part D in Minnesota. Generic dutasteride is covered by the vast majority of Part D plans available in Minnesota. Under the Medicare Prescription Payment Plan restructuring that took full effect in 2025, most beneficiaries with standard Part D coverage pay $0 to $47 per month for a Tier 2 generic. The Medicare Part D "extra help" (low-income subsidy) program can reduce that further to a few dollars per month. Brand Avodart, when covered at all, typically sits at Tier 4 or Tier 5, with monthly cost-sharing between $95 and $200 depending on the plan.

Commercial employer plans in Minnesota. Major Minnesota insurers (Blue Cross and Blue Shield of Minnesota, HealthPartners, Medica, PreferredOne, UCare) generally place generic dutasteride on Tier 1 or Tier 2 with copays in the $5 to $30 range. Formulary specifics change each plan year. The most reliable way to verify your 2026 copay is to check your plan's online drug formulary tool or call the member services number on the back of your insurance card.

Individual and ACA marketplace plans. Minnesota's state marketplace (MNsure) offers silver, gold, and platinum plans from the same major insurers listed above. Generic dutasteride is typically covered at the same Tier 1-2 level as employer plans. Cost-sharing before the deductible is met varies widely; some plans apply the prescription copay even before the deductible, others do not.

Brand Avodart is rarely the right financial choice for a commercially insured Minnesota patient. If a prescriber writes for brand Avodart by name with "DAW-1" (dispense as written), the patient will almost always pay more than if the generic is allowed to be dispensed. Generic dutasteride contains the same active ingredient at the same labeled dose and meets FDA bioequivalence standards. FDA bioequivalence standards for ANDAs are outlined in 21 CFR Part 320.

Can You Get a Dutasteride Prescription via Telehealth in Minnesota?

Telehealth prescribing of dutasteride is fully legal in Minnesota. State law does not require an in-person visit before prescribing oral medications for BPH or for off-label hair loss use.

After the federal COVID-19 public health emergency ended in May 2023, there was concern that telemedicine prescribing of certain medications would be curtailed. For non-controlled substances like dutasteride, those restrictions did not apply. Dutasteride is not a controlled substance under DEA scheduling, so telehealth prescribers in Minnesota can assess, diagnose, and prescribe it through a synchronous video visit or, depending on the platform and the clinical facts, even through an asynchronous intake process.

A Minnesota telehealth visit for dutasteride typically proceeds as follows: the patient completes an intake form covering urinary symptoms (for BPH) or hair loss history (for off-label androgenetic alopecia use), uploads any relevant labs (PSA, if available), and connects with a licensed prescriber. If the prescriber determines dutasteride is appropriate, a prescription is sent electronically to the patient's chosen pharmacy in Minnesota.

HealthRX connects patients with board-certified physicians licensed in Minnesota who can evaluate dutasteride candidacy during a telehealth visit. Prior to starting dutasteride, a baseline PSA level is generally recommended because the drug reduces PSA by approximately 50% after six months of use. The REDUCE trial (N=8,231) established this PSA suppression effect and demonstrated that dutasteride reduced the relative risk of prostate cancer detection by 22.8% vs. placebo over four years.

What Is the Cheapest Way to Get Dutasteride in Minnesota?

For most Minnesota patients, the cheapest path to dutasteride is a generic 0.5 mg capsule purchased at retail with a GoodRx or RxSaver coupon, bringing the price to roughly $18 to $25 per month. That beats compounded versions on cost unless a topical or non-standard formulation is medically necessary.

Here is a ranked breakdown from lowest to highest typical monthly cost for a Minnesota patient:

1. Generic dutasteride with discount coupon, no insurance used ($18-$25): Works at most major Minnesota pharmacies. GoodRx prices are generally available without enrollment.

2. Generic dutasteride through employer plan or Medicare Part D ($0-$30): Best when your plan places it on Tier 1 or Tier 2. Always check whether running through insurance or paying cash is cheaper; counter-intuitive as it sounds, the cash coupon price sometimes beats the insurance copay for generic drugs.

3. Generic dutasteride through Minnesota Medicaid (Medical Assistance) ($0-$3): Lowest cost for eligible patients, but requires prior authorization for BPH diagnosis.

4. Compounded dutasteride from 503A pharmacy (~$40): Appropriate only when a custom formulation (topical, different concentration, or combination product) is clinically indicated.

5. Brand Avodart with no insurance or poor coverage (~$290): Avoid this route unless a specific manufacturer copay card brings the out-of-pocket cost below generic levels.

GSK savings programs. GSK has historically offered a patient assistance program for Avodart through their Medicine Assistance Tool. Eligibility is income-based and typically restricted to patients without adequate insurance coverage. For 2026, patients can check current eligibility at GSK's official assistance portal. These programs are most relevant for uninsured patients who, for some clinical reason, require brand Avodart rather than generic dutasteride.

Manufacturer copay cards for brand Avodart are generally not valid for Medicare or Medicaid beneficiaries due to federal anti-kickback rules. Commercial plan patients may use them, but the resulting brand price still often equals or exceeds the cash price for the generic.

Clinical Background: Why Dutasteride Is Prescribed

Understanding the clinical rationale helps patients and their providers make better coverage and formulary arguments to insurers.

Dutasteride inhibits both type 1 and type 2 isoforms of 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). Finasteride, the other common 5-alpha reductase inhibitor, blocks only type 2. By blocking both isoforms, dutasteride reduces serum DHT by approximately 90-95%, compared to roughly 70% with finasteride, according to pharmacodynamic data cited in the FDA prescribing information.

BPH. The COMBAT trial (N=4,844 to 4 years) found that the combination of dutasteride 0.5 mg plus tamsulosin 0.4 mg reduced the relative risk of clinical BPH progression by 44% versus tamsulosin alone (P<0.001). PubMed PMID 18279503 Minnesota Medicaid's PA requirement is structured around this evidence base; the reviewer wants to see that BPH is documented before approving a 5-alpha reductase inhibitor.

Androgenetic alopecia (off-label). The Eun et al. randomized trial cited above was one of the first controlled studies of topical dutasteride for hair loss. Oral dutasteride has been studied more extensively in Korea and Japan. A 2022 systematic review of six randomized controlled trials (N=917 total) found that oral dutasteride 0.5 mg produced greater increases in total hair count at 24 weeks compared to oral finasteride 1 mg. PubMed PMID 35579937 Minnesota insurers rarely cover dutasteride for hair loss because the FDA label does not include that indication, but some plans cover it as off-label when accompanied by a letter of medical necessity.

Safety notes. Dutasteride carries a pregnancy Category X warning; the drug is absorbed through skin and capsules must not be handled by pregnant women or women who may become pregnant. PSA values are reduced by approximately 50% after six months; clinicians interpreting PSA for prostate cancer screening in a man on dutasteride should double the observed value to estimate the expected untreated level. The FDA prescribing label states: "To interpret an isolated PSA value in a man treated with dutasteride for six months or more, the PSA value should be doubled for comparison with normal ranges in untreated men." FDA label, Avodart (dutasteride)

Minnesota-Specific Considerations for Patients Starting Dutasteride

Minnesota residents face a few practical details that patients in other states do not.

Prescription monitoring. Minnesota participates in the Prescription Monitoring Program (PMP) through the Minnesota PDMP system. Dutasteride is not a scheduled substance, so the PDMP is not directly relevant, but prescribers ordering dutasteride through telehealth are still subject to standard Minnesota prescribing standards and may review the PDMP for context when ordering hormone-related medications.

Pharmacy density in rural MN. Patients in greater Minnesota (areas outside the Twin Cities metro) may have limited local pharmacy options. Mail-order pharmacy through a Part D plan or a PBM mail-order service can deliver 90-day supplies of generic dutasteride for the cost of a two-month copay in many plans, reducing per-dose cost and travel burden.

Minnesota Board of Pharmacy and compounding. The Minnesota Board of Pharmacy actively inspects 503A pharmacies. Patients asking a telehealth platform to route their compounded dutasteride prescription should confirm the compounding pharmacy holds a current Minnesota license before the prescription is filled. Out-of-state 503A pharmacies shipping to Minnesota must hold a valid non-resident pharmacy license issued by the Minnesota Board.

PSA baseline before starting. The American Urological Association (AUA) 2022 guideline on surgical and medical management of BPH states: "A baseline PSA should be measured before initiating 5-alpha reductase inhibitor therapy in men at risk for prostate cancer." AUA guideline referenced at PubMed PMID 35679268 Any Minnesota prescriber ordering dutasteride via telehealth should arrange a lab order for PSA through a patient's local lab (LabCorp, Quest, or a health system lab) before or concurrent with starting the drug.